4.5 Article

AIRE activated tissue specific genes have histone modifications associated with inactive chromatin

期刊

HUMAN MOLECULAR GENETICS
卷 18, 期 24, 页码 4699-4710

出版社

OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddp433

关键词

-

资金

  1. The Wellcome Trust
  2. EU FP6
  3. European Regional Fund
  4. Archimedes Foundation
  5. Estonian Science Foundation [6663, 7559, 7197]
  6. EU European Regional Development Fund through the Estonian Centre of Excellence in Genomics
  7. Estonian Ministry of Education and Research [SF0180026s09]

向作者/读者索取更多资源

The Autoimmune Regulator (AIRE) protein is expressed in thymic medullary epithelial cells, where it promotes the ectopic expression of tissue-restricted antigens needed for efficient negative selection of developing thymocytes. Mutations in AIRE cause APECED syndrome, which is characterized by a breakdown of self-tolerance. The molecular mechanism by which AIRE increases the expression of a variety of different genes remains unknown. Here, we studied AIRE-regulated genes using whole genome expression analysis and chromatin immunoprecipitation. We show that AIRE preferentially activates genes that are tissue-specific and characterized by low levels of initial expression in stably transfected HEK293 cell model and mouse thymic medullary epithelial cells. In addition, the AIRE-regulated genes lack active chromatin marks, such as histone H3 trimethylation (H3K4me3) and acetylation (AcH3), on their promoters. We also show that during activation by AIRE, the target genes acquire histone H3 modifications associated with transcription and RNA polymerase II. In conclusion, our data show that AIRE is able to promote ectopic gene expression from chromatin associated with histone modifications characteristic to inactive genes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

Allergoid-mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

Cristina Benito-Villalvilla, Mario Perez-Diego, Alba Angelina, Kai Kisand, Ana Rebane, Jose Luis Subiza, Oscar Palomares

Summary: Allergoid-mannan conjugates can reprogram monocyte differentiation into stable tolerogenic DCs through epigenetic and metabolic reprogramming mechanisms, and may play an important role in inducing allergen tolerance during allergen-specific immunotherapy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Infectious Diseases

Antibody levels remain high to one-year's follow-up after moderate and severe COVID-19, but not after mild cases

Anne Kallaste, Kalle Kisand, Agnes Aart, Kai Kisand, Part Peterson, Margus Lember

Summary: This study followed 123 COVID-19 patients for one year and found sustained antibody levels in moderate and severe patients after one year. Vaccination of patients with mild disease is important to raise antibody levels to a protective level.

INFECTIOUS DISEASES (2022)

Article Cell Biology

Divalent Metal Ions Boost Effect of Nucleic Acids Delivered by Cell-Penetrating Peptides

Maria Maloverjan, Kaert Padari, Aare Abroi, Ana Rebane, Margus Pooga

Summary: This study reveals that the incorporation of calcium and magnesium ions into CPP-oligonucleotide nanoparticles can enhance transfection efficiency without increasing cytotoxicity. This discovery may contribute to improving the efficacy of CPP-mediated transfection in clinical applications.
Article Cell Biology

Epigenetic quantification of immunosenescent CD8+ TEMRA cells in human blood

Ahto Salumets, Liina Tserel, Anna P. Rumm, Lehte Turk, Kulli Kingo, Kai Saks, Astrid Oras, Raivo Uibo, Riin Tamm, Hedi Peterson, Kai Kisand, Part Peterson

Summary: Age-related changes in T-cell populations play an important role in immunosenescence. CD8(+) TEMRA cells and their subsets have characteristics of cellular senescence and increase in older individuals and age-related chronic inflammatory diseases. CD8(+) TEMRA proportions correlate with cytomegalovirus (CMV) antibody levels but not with chronological age. TRANCE/RANKL levels are associated with differentiated T-cell populations, including CD8(+) TEMRA and its CD28(-) subsets. Deep-amplicon bisulfite sequencing can be used to predict CD8(+) TEMRA cell proportions as a biomarker of immunosenescence.

AGING CELL (2022)

Article Multidisciplinary Sciences

Whole-genome sequencing reveals host factors underlying critical COVID-19

Athanasios Kousathanas, Erola Pairo-Castineira, Konrad Rawlik, Alex Stuckey, Christopher A. Odhams, Susan Walker, Clark D. Russell, Tomas Malinauskas, Yang Wu, Jonathan Millar, Xia Shen, Katherine S. Elliott, Fiona Griffiths, Wilna Oosthuyzen, Kirstie Morrice, Sean Keating, Bo Wang, Daniel Rhodes, Lucija Klaric, Marie Zechner, Nick Parkinson, Afshan Siddiq, Peter Goddard, Sally Donovan, David Maslove, Alistair Nichol, Malcolm G. Semple, Tala Zainy, Fiona Maleady-Crowe, Linda Todd, Shahla Salehi, Julian Knight, Greg Elgar, Georgia Chan, Prabhu Arumugam, Christine Patch, Augusto Rendon, David Bentley, Clare Kingsley, Jack A. Kosmicki, Julie E. Horowitz, Aris Baras, Goncalo R. Abecasis, Manuel A. R. Ferreira, Anne Justice, Tooraj Mirshahi, Matthew Oetjens, Daniel J. Rader, Marylyn D. Ritchie, Anurag Verma, Tom A. Fowler, Manu Shankar-Hari, Charlotte Summers, Charles Hinds, Peter Horby, Lowell Ling, Danny McAuley, Hugh Montgomery, Peter J. M. Openshaw, Paul Elliott, Timothy Walsh, Albert Tenesa, Angie Fawkes, Lee Murphy, Kathy Rowan, Chris P. Ponting, Veronique Vitart, James F. Wilson, Jian Yang, Andrew D. Bretherick, Richard H. Scott, Sara Clohisey Hendry, Loukas Moutsianas, Andy Law, Mark J. Caulfield, J. Kenneth Baillie

Summary: This study used whole-genome sequencing to compare the genomes of 7,491 critically ill individuals with 48,400 controls, and identified 23 independent variants associated with critical COVID-19. The research found multiple genes that are involved in interferon signaling, leukocyte differentiation, and blood-type antigen secretion to be associated with critical illness.

NATURE (2022)

Letter Biochemistry & Molecular Biology

Studying severe long COVID to understand post-infectious disorders beyond COVID-19

Petter Brodin, Giorgio Casari, Liam Townsend, Cliona O'Farrelly, Ivan Tancevski, Judith Loeffler-Ragg, Trine H. Mogensen, Jean Laurent Casanova

NATURE MEDICINE (2022)

Article Multidisciplinary Sciences

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jeremy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jeremie Rosain, Quentin Philippot, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina Garcia-Prat, Lucy Bizien, Alba Parra-Martinez, Rui Yang, Liis Haljasmagi, Melanie Migaud, Karita Sarekannu, Julia Maslovskaja, Nicolas de Prost, Yacine Tandjaoui-Lambiotte, Charles-Edouard Luyt, Blanca Amador-Borrero, Alexandre Gaudet, Julien Poissy, Pascal Morel, Pascale Richard, Fabrice Cognasse, Jesus Troya, Sophie Trouillet-Assant, Alexandre Belot, Kahina Saker, Pierre Garcon, Jacques G. Riviere, Jean-Christophe Lagier, Stephanie Gentile, Lindsey B. Rosen, Elana Shaw, Tomohiro Morio, Junko Tanaka, David Dalmau, Pierre-Louis Tharaux, Damien Sene, Alain Stepanian, Bruno Megarbane, Vasiliki Triantafyllia, Arnaud Fekkar, James R. Heath, Jose Luis Franco, Juan-Manuel Anaya, Jordi Sole-Violan, Luisa Imberti, Andrea Biondi, Paolo Bonfanti, Riccardo Castagnoli, Ottavia M. Delmonte, Yu Zhang, Andrew L. Snow, Steven M. Holland, Catherine M. Biggs, Marcela Moncada-Velez, Andres Augusto Arias, Lazaro Lorenzo, Soraya Boucherit, Dany Anglicheau, Anna M. Planas, Filomeen Haerynck, Sotirija Duvlis, Tayfun Ozcelik, Sevgi Keles, Ahmed A. Bousfiha, Jalila El Bakkouri, Carolina Ramirez-Santana, Stephane Paul, Qiang Pan-Hammarstrom, Lennart Hammarstrom, Annabelle Dupont, Alina Kurolap, Christine N. Metz, Alessandro Aiuti, Giorgio Casari, Vito Lampasona, Fabio Ciceri, Lucila A. Barreiros, Elena Dominguez-Garrido, Mateus Vidigal, Mayana Zatz, Diederik van de Beek, Sabina Sahanic, Ivan Tancevski, Yurii Stepanovskyy, Oksana Boyarchuk, Yoko Nukui, Miyuki Tsumura, Loreto Vidaur, Stuart G. Tangye, Sonia Burrel, Darragh Duffy, Lluis Quintana-Murci, Adam Klocperk, Nelli Y. Kann, Anna Shcherbina, Yu-Lung Lau, Daniel Leung, Matthieu Coulongeat, Julien Marlet, Rutger Koning, Luis Felipe Reyes, Angelique Chauvineau-Grenier, Fabienne Venet, Guillaume Monneret, Michel C. Nussenzweig, Romain Arrestier, Idris Boudhabhay, Hagit Baris-Feldman, David Hagin, Joost Wauters, Isabelle Meyts, Adam H. Dyer, Sean Kennelly, Nollaig M. Bourkeh, Rabih Halwan, Fatemeh Saheb Sharif-Askar, Karim Dorgham, Jerome Sallette, Souad Mehlal Sedkaoui, Suzan AlKhater, Raul Rigo-Bonnin, Francisco Morandeira, Lucie Roussel, Donald C. Vinh, Christian Erikstrup, Antonio Condino-Neto, Carolina Prando, Anastasiia Bondarenko, Andras N. Spaan, Laurent Gilardin, Jacques Fellay, Stanislas Lyonnet, Kaya Bilguvar, Richard P. Lifton, Shrikant Mane, Mark S. Anderson, Bertrand Boisson, Vivien Beziat, Shen-Ying Zhang, Evangelos Andreakos, Olivier Hermine, Aurora Pujol, Part Peterson, Trine H. Mogensen, Lee Rowen, James Mond, Stephanie Debette, Xavier de Lamballerie, Charles Burdet, Lila Bouadma, Marie Zins, Pere Soler-Palacin, Roger Colobran, Guy Gorochov, Xavier Solanich, Sophie Susen, Javier Martinez-Picado, Didier Raoult, Marc Vasse, Peter K. Gregersen, Lorenzo Piemonti, Carlos Rodriguez-Gallego, Luigi D Notarangelo, Helen C. Su, Kai Kisand, Satoshi Okada, Anne Puel, Emmanuelle Jouanguy, Charles M. Rice, Pierre Tiberghien, Qian Zhang, Jean-Laurent Casanova, Laurent Abel, Aurelie Cobat

Summary: This study investigates the impact of autoimmunity on COVID-19-related deaths and finds that individuals carrying autoantibodies neutralizing type I interferons are at higher risk of death, with the risk decreasing with age.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Oncology

Psychostimulant-induced aberrant DNA methylation in an in vitro model of human peripheral blood mononuclear cells

Kaili Anier, Kelli Somelar, Kulli Jaako, Margret Alttoa, Kerli Sikk, Raul Kokassaar, Kai Kisand, Anti Kalda

Summary: This study found that repeated exposure to psychostimulants decreases the enzymatic activity of TETs in PBMCs. Co-treatment with decitabine can restore TETs levels and modulate immune response after repeated cocaine exposure. These findings may contribute to further research on biomarkers and therapeutic approaches for psychostimulant use.

CLINICAL EPIGENETICS (2022)

Article Cell Biology

Enhanced Cognition and Neurogenesis in miR-146b Deficient Mice

Keerthana Chithanathan, Kelli Somelar, Monika Jurgenson, Tamara Zarkovskaja, Kapilraj Periyasamy, Ling Yan, Nathaniel Magilnick, Mark P. Boldin, Ana Rebane, Li Tian, Alexander Zharkovsky

Summary: This study found that miR-146b is abundantly expressed in neuronal cells and miR-146a is mainly expressed in microglia and astroglia. miR-146b deficiency leads to anxiety-like behaviors and enhanced cognition, as well as an increase in the number of neurons and a decrease in the abundance of astroglia. Furthermore, it was discovered that the deficiency of miR-146b is associated with elevated expression of the gene Gdnf in the hippocampus.
Article Immunology

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Qian Zhang, Andres Pizzorno, Lisa Miorin, Paul Bastard, Adrian Gervais, Tom Le Voyer, Lucy Bizien, Jeremy Manry, Jeremie Rosain, Quentin Philippot, Kelian Goavec, Blandine Padey, Anastasija Cupic, Emilie Laurent, Kahina Saker, Martti Vanker, Karita Saerekannu, Tamara Garcia-Salum, Marcela Ferres, Nicole Le Corre, Javier Sanchez-Cespedes, Maria Balsera-Manzanero, Jordi Carratala, Pilar Retamar-Gentil, Gabriela Abelenda-Alonso, Adoracion Valiente, Pierre Tiberghien, Marie Zins, Stephanie Debette, Isabelle Meyts, Filomeen Haerynck, Riccardo Castagnoli, Luigi D. Notarangelo, Luis I. Gonzalez-Granado, Nerea Dominguez-Pinilla, Evangelos Andreakos, Vasiliki Triantafyllia, Carlos Rodriguez-Gallego, Jordi Sole-Violan, Jose Juan Ruiz-Hernandez, Felipe Rodriguez de Castro, Jose Ferreres, Marisa Briones, Joost Wauters, Lore Vanderbeke, Simon Feys, Chen-Yen Kuo, Wei-Te Lei, Cheng-Lung Ku, Galit Tal, Amos Etzioni, Suhair Hanna, Thomas Fournet, Jean-Sebastien Casalegno, Gregory Queromes, Laurent Argaud, Etienne Javouhey, Manuel Rosa-Calatrava, Elisa Cordero, Teresa Aydillo, Rafael A. Medina, Kai Kisand, Anne Puel, Emmanuelle Jouanguy, Laurent Abel, Aurelie Cobat, Sophie Trouillet-Assant, Adolfo Garcia-Sastre, Jean-Laurent Casanova

Summary: In a study of 279 international patients with hypoxemic influenza pneumonia, 4.6% of patients were found to have autoantibodies neutralizing IFN-alpha and/or -omega, which may contribute to life-threatening COVID-19 pneumonia and severe adverse reactions to yellow fever vaccine. These antibodies increased influenza virus replication and were more prevalent in patients under 70 years old compared to the general population. Patients with high concentrations of both IFN-alpha 2 and IFN-omega antibodies had the highest risk of critical influenza.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Cell Biology

Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNa and B cell subsets

Hannah F. Bradford, Liis Haljasmagi, Madhvi Menon, Thomas C. R. McDonnell, Karita Sarekannu, Martti Vanker, Part Peterson, Chris Wincup, Rym Abida, Raquel Fernandez Gonzalez, Vincent Bondet, Darragh Duffy, David A. Isenberg, Kai Kisand, Claudia Mauri

Summary: Systemic lupus erythematosus (SLE) patients often exhibit increased expression of type I interferon (IFN)-regulated genes. In our study of 501 SLE patients, we found that 73 (14%) had autoantibodies against IFN-alpha (anti-IFN-Abs). The presence of neutralizing anti-IFN-Abs in 4.2% of patients correlated with low IFN-alpha protein levels, inhibition of IFN-I downstream gene signatures, and inactive disease score. These neutralizing anti-IFN-Abs were found to play a role in controlling SLE pathogenesis, specifically in regulating B cell populations.

CELL REPORTS MEDICINE (2023)

Article Pharmacology & Pharmacy

The Development of Cell-Penetrating Peptides for Efficient and Selective In Vivo Expression of mRNA in Spleen Tissue

Ly Porosk, Heleri Heike Haerk, Piret Arukuusk, Uku Haljasorg, Part Peterson, Kaido Kurrikoff

Summary: mRNA-based therapeutics have great potential as preventive vaccines, but the challenge lies in delivering mRNA to non-hepatic tissues, such as the spleen and lymph nodes, in order to transition from preventive to therapeutic vaccines. This study discovered new cell-penetrating peptides NF424 and NF436 that can selectively deliver mRNA to the spleen without the need for active targeting mechanisms. The majority of mRNA expression occurs in dendritic cells within the spleen, making NF424 and NF436 promising candidates for cancer immunotherapeutic applications with tumor antigens.

PHARMACEUTICS (2023)

Article Cell Biology

Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine

Paul Naaber, Liina Tserel, Kadri Kangro, Marite Punapart, Epp Sepp, Virge Jurjenson, Jaanika Karner, Liis Haljasmagi, Uku Haljasorg, Marilin Kuusk, Eve Sankovski, Anu Planken, Mart Ustav, Eva Zusinaite, Joachim M. Gerhold, Kai Kisand, Part Peterson

Summary: This study conducted a longitudinal analysis on 111 vaccinated individuals and found that the third dose of the BNT162b2 vaccine restores high levels of blocking antibodies and enhances T cell responses to the Omicron variant.

CELL REPORTS MEDICINE (2022)

Article Oncology

Depletion of Mannose Receptor-Positive Tumor-associated Macrophages via a Peptide-targeted Star-shaped Polyglutamate Inhibits Breast Cancer Progression in Mice

Anni Lepland, Alessio Malfanti, Uku Haljasorg, Eliana K. Asciutto, Monica Pickholz, Mauro Bringas, Snezana Dordevic, Liis Salumae, Paert Peterson, Tambet Teesalu, Maria J. Vicent, Pablo Scodeller

Summary: This study developed a novel TAM-depleting agent and demonstrated its efficacy in a triple-negative breast cancer mouse model. The agent specifically targets CD206+ TAMs and does not show acute liver or kidney toxicity in vivo. Treatment with this agent showed potential benefits in reducing tumor progression and modulating the immune system. This research represents a novel design of a peptide-targeted nanotherapeutic for TAM depletion.

CANCER RESEARCH COMMUNICATIONS (2022)

暂无数据